What Happened? Shares of medical device company Penumbra (NYSE:PEN) jumped 13.6% in the afternoon session after the company reported impressive fourth-quarter 2024 results, which blew past analysts' ...
Penumbra stock gapped up Wednesday after the medtech company beat fourth-quarter expectations, though its revenue guidance came in shy. Shares of medical device company Penumbra (NYSE:PEN ...
Penumbra stock climbs after Q4 earnings surpass expectations, with sales up 10.8% Y/Y. Analysts raise price targets as the ...
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s ...
Penumbra (NYSE:PEN – Get Free Report) had its price target hoisted by equities research analysts at Truist Financial from $285.00 to $325.00 in a note issued to investors on Wednesday,Benzinga reports ...
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies ...